COMP <GO>
ARMP vs HUMA // GROSS PROFIT MARGIN
Armata Pharmaceuticals Inc. (NYSE) VS. Humacyte Inc. (NASDAQ) • 15-METRIC TALLY: ARMP 0
— HUMA 2
■ METRIC PARITY
LAST: $3.28 (+0.92%) • MKT CAP: $120.8M
gross-margins
—
LAST: $0.41 (-12.47%) • MKT CAP: $130.5M
gross-margins
-30.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARMP VS. HUMA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARMP | HUMA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | -30.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -21.77% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.8 | 51.1 | -7.26 | HUMA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $120.8M | $130.5M | -$9.7M | HUMA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARMP REV | HUMA REV | ARMP GROSS % | HUMA GROSS % | ARMP FCF | HUMA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $2.0M | — | -50.0% | -$26.3M | -$105.9M |
| FY 2024 | $0 | $0 | — | — | -$39.4M | -$99.7M |
| FY 2023 | $0 | $0 | — | — | -$47.4M | -$73.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARMP // BETA —
HUMA // BETA —